Literature DB >> 4331962

The regulation of growth hormone secretion from the isolated rat anterior pituitary in vitro. The role of adenosine 3':5'-cyclic monophosphate.

R B Ewart, K W Taylor.   

Abstract

1. The release of growth hormone from isolated fragments of rat anterior pituitary tissue incubated in vitro was studied by employing a double-antibody radioimmunoassay. 2. In the absence of added stimuli, two phases of hormone release could be distinguished, an early phase of 2h duration and a subsequent late phase. In the early phase, hormone release was rapid but could be significantly decreased by calcium depletion and by 2,4-dinitrophenol whereas the rate of release in the late phase was uninfluenced by these incubation conditions. These results have been interpreted as indicating the existence of a secretory component in the early phase of release. 3. In subsequent experiments, the effects of various agents on the rate of hormone output during the late phase of incubation were investigated. Hormone release was increased by theophylline and by dibutyryl cyclic AMP (N(6)-2'-O-dibutyryl-adenosine 3':5'-cyclic monophosphate), the response to both of these agents being related to the concentration of the stimulant employed. 4. The stimulation of growth hormone output by theophylline was significantly decreased by calcium deprivation and by 2,4-dinitrophenol. The response to dibutyryl cyclic AMP was diminished by 2,4-dinitrophenol, iodoacetate and 2-deoxyglucose but not by malonate or colchicine. 5. Arginine, beta-hydroxybutyrate, albumin-bound palmitate and variation in the glucose concentration of the incubation medium over a wide range were without any statistically significant effect on the rate of hormone release from either control pituitary fragments or those subject to secretory stimulation by dibutyryl cyclic AMP. 6. It is suggested that the regulation of growth hormone secretion is mediated by cyclic AMP (adenosine 3':5'-cyclic monophosphate). The secretion observed in response to cyclic AMP requires the presence of ionized calcium and a source of metabolic energy but is independent of pituitary protein synthesis de novo. The integrity of the glycolytic pathway of glucose metabolism appears to be essential for cyclic AMP-stimulated growth hormone secretion to occur.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4331962      PMCID: PMC1177260          DOI: 10.1042/bj1240815

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  ATP, calcium uptake and growth hormone release.

Authors:  J G. Schofield; Margaret Stead
Journal:  FEBS Lett       Date:  1971-03-05       Impact factor: 4.124

2.  EFFECT OF HYPOTHALAMIC EXTRACTS ON RELEASE OF GROWTH HORMONE IN VITRO.

Authors:  A V SCHALLY; S L STEELMAN; C Y BOWERS
Journal:  Proc Soc Exp Biol Med       Date:  1965-05

3.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

4.  An evaluation of a chemical method for the estimation of oestriol, oestrone and oestradiol-17 beta in human urine.

Authors:  J B BROWN; R D BULBROOK; F C GREENWOOD
Journal:  J Endocrinol       Date:  1957-11       Impact factor: 4.286

5.  Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles.

Authors:  P J Randle; E A Newsholme; P B Garland
Journal:  Biochem J       Date:  1964-12       Impact factor: 3.857

Review 6.  The ultrastructure of endocrine glands.

Authors:  D W Fawcett; J A Long; A L Jones
Journal:  Recent Prog Horm Res       Date:  1969

7.  Some effects of energy-transfer inhibitors and of Ca++-free or K+-enhanced media on the release of luteinizing hormone (LH) from the rat pituitary gland in vitro.

Authors:  M H Samli; I I Geschwind
Journal:  Endocrinology       Date:  1968-02       Impact factor: 4.736

8.  Effects of cortisol and diethylstilbestrol on growth hormone release by rat pituitary in vitro.

Authors:  C A Birge; G R Peake; I K Mariz; W H Daughaday
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

9.  Role of cyclic 3',5'-adenosine monophosphate in the release of growth hormone in vitro.

Authors:  J G Schofield
Journal:  Nature       Date:  1967-09-23       Impact factor: 49.962

10.  Measurement of growth hormone released by ox anterior-pituitary slices in vitro.

Authors:  J G Schofield
Journal:  Biochem J       Date:  1967-05       Impact factor: 3.857

View more
  7 in total

1.  In vitro incorporation of (3H)threonine and (3H)glucose by the mucous and serous cells of the human bronchial submucosal gland. A quantitative electron microscope study.

Authors:  B Meyrick; L Reid
Journal:  J Cell Biol       Date:  1975-11       Impact factor: 10.539

2.  Colchicine binding to bovine anterior pituitary slices and inhibition of growth-hormone release.

Authors:  P Sheterline; J G Schofield; F Mira
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

3.  Control of pancreatic amylase release in vitro: effects of ions, cyclic AMP, and colchicine.

Authors:  L Benz; B Eckstein; E K Matthews; J A Williams
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

4.  The effect of prostaglandins on ox pituitary content of adenosine 3':5'-cyclic monophosphate and the release of growth hormone.

Authors:  R H Cooper; M McPherson; J G Schofield
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

5.  Role of microtubules in the intracellular transport of growth hormone.

Authors:  S L Howell; M Tyhurst
Journal:  Cell Tissue Res       Date:  1978-06-26       Impact factor: 5.249

6.  Effect of colchicine on rat mast cells.

Authors:  D Lagunoff; E Y Chi
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

7.  Hormone secretion by cells dissociated from rat anterior pituitaries.

Authors:  C R Hopkins; M G Farquhar
Journal:  J Cell Biol       Date:  1973-11       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.